Target intelligence / Profile preview

Family with sequence similarity 95 member A (FAM95A)

Target
FAM95A
Molecular classification
Other
01

Overview

Family with sequence similarity 95 member A (FAM95A) is a protein-coding gene, but there is extremely limited functional and biological information available in the scientific literature. It does not appear to fall within any standard target class such as receptor, enzyme, transporter, or transcription factor, and there is no evidence it serves as a therapeutic target or has a defined role in human disease based on current sources[1].

Other names
DKFZp434H0923FAM95A

Beyond the preview

Go deeper on Family with sequence similarity 95 member A (FAM95A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 95 member A (FAM95A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call